GPS Wealth Strategies Group’s Emergent Biosolutions EBS Stock Holding History

GPS Wealth Strategies Group’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-44	Closed	-$281	–	1672
2025 Q2	$281	Hold	44	–	–	﹤0.01%	1530
2025 Q1	$214	Hold	44	–	–	﹤0.01%	1427
2024 Q4	$421	Hold	44	–	–	﹤0.01%	1331
2024 Q3	$367	Hold	44	–	–	﹤0.01%	1341
2024 Q2	$300	Sell	44 -18	-29%	-$77	﹤0.01%	1311
2024 Q1	$157	Hold	62	–	–	﹤0.01%	1222
2023 Q4	$149	Sell	62 -760	-92%	-$1.79K	﹤0.01%	1220
2023 Q3	$2.79K	Hold	822	–	–	﹤0.01%	1076
2023 Q2	$6.04K	Buy	822 +44	+6%	+$408	﹤0.01%	949
2023 Q1	$8.06K	Buy	+778	New	+$9.4K	﹤0.01%	874
2022 Q4	–	Sell	-18	Closed	–	–	390
2022 Q3	$0	Hold	18	–	–	﹤0.01%	1136
2022 Q2	$1K	Hold	18	–	–	﹤0.01%	1059
2022 Q1	$1K	Sell	18 -54	-75%	-$2.38K	﹤0.01%	990
2021 Q4	$3K	Hold	72	–	–	﹤0.01%	939
2021 Q3	$4K	Sell	72 -256	-78%	-$15.5K	﹤0.01%	860
2021 Q2	$21K	Sell	328 -209	-39%	-$13.4K	0.01%	570
2021 Q1	$49K	Buy	+537	New	+$55K	0.01%	383

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

OHA

Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

GPS Wealth Strategies Group's EBS Position: Q3 2025 in Review

GPS Wealth Strategies Group sold out of Emergent Biosolutions (EBS) in Q3 2025, closing a stake of 44 shares — an estimated $281 sold.

GPS Wealth Strategies Group first reported a position in EBS in Q1 2021 and held it in 17 quarters. The position peaked at $49K in Q1 2021. 169 funds tracked by Wall St. Rank hold EBS as of Q3 2025.

GPS Wealth Strategies Group reported no remaining Emergent Biosolutions position as of Q3 2025 after selling out during the quarter.
GPS Wealth Strategies Group sold 44 Emergent Biosolutions shares in Q3 2025, an estimated $281.
GPS Wealth Strategies Group first reported a position in Emergent Biosolutions in Q1 2021 and held it in 17 quarters.
GPS Wealth Strategies Group's Emergent Biosolutions position peaked at $49K in Q1 2021.
169 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q3 2025, filed 3 Nov 2025.